Brotizolam is not approved for marketing in the United States by the U.S. Food and Drug Administration. Very little information is available on the passage of brotizolam into milk, although amounts in milk appear to be very low. An alternate drug might be preferred, especially while nursing a newborn or preterm infant. If brotizolam is used, monitor the infant for sedation, poor feeding and poor weight gain.
溴替唑仑未被美国食品药品监督管理局批准在美国上市。关于溴替唑仑进入乳汁的信息非常少，不过乳汁中的含量似乎很低。可能更倾向于选用其他药物，尤其是在哺育新生儿或早产儿期间。如果使用溴替唑仑，需监测婴儿是否出现镇静、喂养困难和体重增加缓慢的情况。
